Humanigen Inc (fka HGENQ)

[10nisman]

Well, we got a little more information as to the company's intention with regard to manufacturing lenz. Whereas last quarter, we were warned that lenz production could actually be halted after mid-year, we are now told, "If an EUA or CMA for lenzilumab is not received in the third quarter of 2021, the company would seek to decrease its spending on lenzilumab production." But, we're already through half of the 3rd Quarter.

So, not only is HGEN going to burn through another $100 million this quarter but its going to shutdown production in 49 days without approval. HGEN will be trading in the mid single digits in a couple months if they don't get approval. But, keep pumping away while Management keeps dumping.